A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
To provide treating physicians with experience with ILUVIEN as well as monitoring its safety
(and effectiveness) in a real-life chronic diabetic macular edema (DME) patients judged
insufficiently responsive to available therapies.
Phase:
Phase 4
Details
Lead Sponsor:
Association for Innovation and Biomedical Research on Light and Image